(Q38305815)

2 September 2017

DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC). (English)

1 reference

enterotoxigenic Escherichia coli

2 September 2017

1 reference

1 reference

Alves AM

1

1 reference

2 September 2017

Lásaro MO

series ordinal

2

1 reference

2 September 2017

Almeida DF

series ordinal

3

1 reference

2 September 2017

Ferreira LC

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

2 September 2017

1 reference

2 September 2017

19

1 reference

2 September 2017

7-8

1 reference

2 September 2017

788-795

1 reference

Epidemiology of diarrhoeal disease: implications for control by vaccines

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Slaying the Hydra all at once or head by head?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Colonization factors of enterotoxigenic Escherichia coli isolated from children with diarrhea in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Analysis of colonization factor antigen I, an adhesin of enterotoxigenic Escherichia coli O78:H11: fimbrial morphology and location of the receptor-binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Monoclonal antibodies against different epitopes on colonization factor antigen I of enterotoxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Immune responses to nucleic acid vaccines to rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

1 reference

7 January 2021

Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA/I fimbriae in mice immunized with naked DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

New vaccine strategies against enterotoxigenic Escherichia coli. I: DNA vaccines against the CFA/I fimbrial adhesin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

The occurence of colonisation factors (CFA/I,CFA/II and E8775) in enterotoxigenicEscherichia coli from various countries in South East Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Immunoglobulin G subclass responses in mice immunized with plasmid DNA encoding the CFA/I fimbria of enterotoxigenic Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Antibody response in mice immunized with a plasmid DNA encoding the colonization factor antigen I of enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Monoclonal antibodies against enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) that cross-react immunologically with heterologous CFAs.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Progress towards a vaccine against enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

New vaccine strategies against enterotoxigenic Escherichia coli. II: Enhanced systemic and secreted antibody responses against the CFA/I fimbriae by priming with DNA and boosting with a live recombinant Salmonella vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900244-9

7 January 2021

10.1016/S0264-410X(00)00244-9

Identifiers

DOI

1 reference

2 September 2017

1 reference